Ignite Creation Date:
2024-05-06 @ 12:27 AM
Last Modification Date:
2024-10-26 @ 10:50 AM
Study NCT ID:
NCT01576705
Status:
COMPLETED
Last Update Posted:
2020-05-13
First Post:
2012-04-11
Brief Title:
Efficacy Assessment of Systematic Treatment With Folinic Acid and Thyroid Hormone on Psychomotor Development of Down Syndrome Young Children
Sponsor:
Institut Jerome Lejeune
Organization:
Institut Jerome Lejeune
Study Overview
Official Title:
Efficacy Assessment of Systematic Treatment With Folinic Acid and Thyroid Hormone on Psychomotor Development of Down Syndrome Young Children
Status:
COMPLETED
Status Verified Date:
2019-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ACTHYF
Brief Summary:
Evaluation of the following in very young children with Down syndrome
the efficacy of systematic treatment with L-thyroxine at controlled doses clinically and by ultrasensitive thyreostimulating hormone TSH assay
the efficacy of systematic folinic acid treatment at a dose of 1 mgkgoid
any interaction between these two treatments
the efficacy of systematic treatment with L-thyroxine at controlled doses clinically and by ultrasensitive thyreostimulating hormone TSH assay
the efficacy of systematic folinic acid treatment at a dose of 1 mgkgoid
any interaction between these two treatments
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None